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Toll-like receptors (TLRs) recognize molecular patterns on various microbes and serve as innate
immune sensors. After cognate ligand recognition, TLRs activate signaling pathways to induce innate
immune defense mechanisms, which eliminate pathogenic microbes, including periodontogenic
bacteria, to a certain extent. Recent ﬁndings have shown that TLR signaling is linked to induction of
autophagy to facilitate direct killing of cytosol-invading bacteria within infected cells. However,
whether autophagy has any regulatory effects on TLR signaling remains unclear. Our recent study
showed that the signaling molecules Toll/interleukin-1 receptor homology domain-containing adaptor
inducing interferon-b and tumor necrosis factor receptor-associated factor 6 are selectively degraded
by autophagy after activation of TLR signal transduction. We found that the nuclear dot protein 52
(NDP52), an autophagy-associated protein, is involved in such degradation, negatively regulating TLR
signaling. However, interestingly, this activity of NDP52 is strictly restricted by the deubiquitinase A20.
Here, we describe an autophagy-associated regulatory function of NDP52 in TLR signaling on the basis
of our recent ﬁndings.
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In innate immunity, pathogen-associated molecular patterns
(PAMPs), which are usually conserved in a wide variety of
microbes, are recognized by various classes of pattern-recognition
receptors (PRRs) [1]. Toll-like receptors (TLRs) are generally
perceived as the major PRRs. In humans, 10 functional TLRs haveciation for Oral Biology. Publishedbeen identiﬁed. Cell surface TLRs (TLR1, TLR2, TLR4, TLR5, and
TLR6) mainly recognize bacterial components, such as membrane
lipoproteins, lipopolysaccharides (LPS), ﬂagella, and ﬁmbriae.
The intracellular TLRs (TLR3, TLR7, TLR8, and TLR9) recognize
viral and bacterial nucleic acids. After recognition of these
cognate PAMPs, TLRs activate cellular signaling pathways to
induce various immune responses.
Periodontal diseases are characterized by various inﬂam-
matory symptoms in the periodontal connective tissue, often
accompanied by destruction of the tissue. The presence of
periodontogenic gram-negative bacteria, such as Porphyromonasby Elsevier B.V. All rights reserved.
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Fig. 1. A20 conceals the mechanism of degradation of TRIF and TRAF6 by
autophagy. (A) TRIF and TRAF6 are selectively degraded after TLR3 engagement
when A20 is silenced. Human bone marrow-derived primary mononuclear cells
were transfected with control siRNA or A20 siRNA. Cells were stimulated for 6 h
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gatibacter actinomycetemcomitans, and Tannerella forsythia, in the
subgingiva is strongly associated with disease development [2].
Periodontal inﬂammation is at least partially triggered by recog-
nition of bacterial PAMPs, such as LPS and ﬁmbriae, by TLRs [3],
but several periodontogenic bacteria have the capability to evade
TLR recognition [4]. The mechanism of how TLR recognition of
PAMPs chronically advances inﬂammatory processes through
involvement of various cell types around the periodontal tissue
has been gaining importance.
TLR signaling is activated via 2 key adaptor molecules:
myeloid differentiation factor 88 (MyD88) and Toll/interleukin
(IL)-1 receptor homology domain-containing adaptor inducing
interferon (IFN)-b (TRIF, also known as TICAM-1) [5]. MyD88 is
involved in signaling mediated by all TLRs except TLR3, whereas
TRIF is only involved in signaling mediated by TLR3 and TLR4.
Activation of the MyD88-dependent pathway is principally
mediated by the E3 ubiquitin ligase tumor necrosis factor recep-
tor-associated factor 6 (TRAF6). TRAF6 catalyzes polyubiquitina-
tion (polyUb) of its target proteins, including IL-1 receptor-
associated kinase-1 and TRAF6 itself [6]. TRAF6-mediated polyUb
activates nuclear factor kB (NF-kB), a transcription factor that
induces a variety of genes, such as the genes coding for cytokines,
adhesion molecules, and antimicrobial molecules. However, the
TRIF-dependent pathway branches into 3 major pathways
that are mediated by TRAF6, receptor-interacting serine/threo-
nine protein kinase 1 (RIP1) and another E3 ubiquitin ligase,
namely, TRAF3 [5]. Both TRAF6- and RIP1-mediated pathways
lead to NF-kB activation. TRAF3 catalyzes polyUb of its target
proteins, including TRAF3 itself and TRAF family member-
associated NF-kB activator-binding kinase 1, which activates a
transcription factor called interferon regulatory factor 3 (IRF3)
that drives transcription of type I IFNs and IFN-related
chemokines [5].
Recent ﬁndings have revealed that TLR signaling regulates the
induction of macroautophagy [7–9]. Macroautophagy (hereafter,
referred to as autophagy) involves sequestration of intracellular
components within autophagosomes, followed by their delivery
to lysosomes and eventual degradation [10]. The major functions
of autophagy in mammals are nutrient supply restoration
during cell starvation, cytoprotection against stressors for
homeostatic quality control, and clearance of cytosol-invading
microbes and viruses. In the case of TLR4-activated autophagy,
TRIF, but not MyD88, serves as an essential mediator of auto-
phagy signaling [8]. However, in the case of TLR7-activated
autophagy, MyD88 serves as a critical mediator [9]. Downstream
of these adaptor proteins, TLR-induced autophagy leads to clear-
ance of cytosol-invading bacteria, such as Salmonella species,
and phagocytosed bacteria, such as Mycobacterium tuberculosis
[8,9,11].
In contrast to the bactericidal effect of autophagy, the effect of
autophagy on TLR signaling is still unclear. Our recent study
suggested that TLR3 may activate autophagy to selectively
degrade TRIF and TRAF6, thus negatively regulating TLR signal
transduction [12]. In addition, an autophagy-associated protein,
nuclear dot protein 52 (NDP52) was found to mediate such
degradation. In this review, we address how the NDP52-asso-
ciated mechanism of autophagy can regulate TLR signaling.with 50 mg/ml poly (I:C). The cells lysates were analyzed by immunoblotting with
antibodies against TRIF, TRAF6, TRAF3, RIP1, A20, and GAPDH (modiﬁed from
Inomata et al. [12]). (B) Autophagosome formation after poly (I:C) stimulation in
bone marrow-derived primary mononuclear cells in which the A20 gene is
silenced. Human bone marrow-derived primary mononuclear cells were trans-
fected with A20 siRNA. The cells were stimulated for 6 h with 50 mg/ml poly (I:C).
The cells were evaluated by electron microscopy (modiﬁed from Inomata et al.
[12]). The magniﬁed photograph represents the area indicated in the square.
Arrowhead shows autophagosome. Scale bar, 2 mm. Original magniﬁcation
3000 .2. A20 conceals a mechanism of selective degradation
of TRIF and TRAF6
Excessive induction of TLR-mediated immune responses
results in the accumulation of pathological damage and occasion-
ally leads to the development of inﬂammatory disorders [13],including periodontal diseases. To prevent this, cells usually
employ mechanisms to suppress TLR signaling at multiple levels.
The deubiquitinase A20 is one of the major negative regulators.
A20 removes polyubiquitin chains from its substrates, such as
TRAF6, TRAF3, and RIP1, to inactivate TLR signaling by inhibiting
signaling downstream of these substrates and NF-kB and IRF3
activation [14]. Expression of A20 is regulated by NF-kB and thus,
A20 functions in a negative feedback loop in TLR signaling.
Consistent with this, we conﬁrmed that A20 expression is
upregulated by the TLR3-stimulant ligand poly (I:C) in HeLa cells
and human bone marrow-derived mononuclear cells (MCs) [12].
Gene silencing of A20 by small interference RNA (siRNA) pro-
moted poly (I:C)-induced gene expression of the NF-kB-driven
cytokines IL-6 and IL-8 and the IRF3-driven chemokine CXCL10;
this indicated that A20, indeed, serves as a negative regulator.
However, unexpectedly, the protein levels of TRIF and TRAF6, but
not of TRAF3 and RIP1, were obviously decreased after poly (I:C)
treatment in A20 gene-silenced cells (Fig. 1A). However, the TRIF
and TRAF6 mRNA levels and glyceraldehyde 3-phosphate protein
level did not change. These observations suggest that A20 can
suppress selective protein degradation mechanisms. Such a func-
tion for A20 in protein degradation is completely inconsistent
with that reported by a previous study showing that A20 can
promote degradation of its target proteins [15].
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Fig. 2. NDP52 mediates selective degradation of TRIF. HeLa cells were transfected
with A20 siRNA along with control siRNA or NDP52 siRNA. Cells were stimulated
for 6 h with 50 mg/ml poly (I:C). The cells lysates were analyzed by immunoblot-
ting with antibodies against TRIF, GAPDH, and NDP52 (modiﬁed from Inomata
et al. [12]).
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We investigated the machinery involved in the selective
degradation of TRIF and TRAF6; this degradation seems to be
absent in the presence of A20. The major protein degradation
systems in eukaryotes are the ubiquitin–proteasome system and
autophagy-mediated lysosomal system. We utilized 2 inhibitors,
the 26S proteasome inhibitor MG-132 and autophagy (or class III
phosphatidylinositol 3 kinase [PI3K]) inhibitor 3-methyladenin
(3-MA). Interestingly, TRIF and TRAF6 degradation in A20-
silenced cells was strongly inhibited by 3-MA but was unaffected
by MG-132 [12].
Generally, autophagy is initiated by formation of the isolated
autophagic membrane (called phagophore) around the target com-
ponents at the phagophore assembly site called ‘‘omegasome-like
structure’’ near the rough endoplasmic reticulum (rER) [16].
The elongated phagophore is closed to form a double-membrane
autophagosome, and the autophagosome matures through docking
and fusion with lysosomes. Subsequently, lysosomal enzymes
degrade the autophagosomal inner membrane and cargo. In A20-
silenced MCs, we observed increased formation of double-mem-
brane autophagosomes after poly (I:C) stimulation (Fig. 1B). Further-
more, TRIF and TRAF6 degradation in A20-silenced cells was
suppressed by the lysosomal protease inhibitors E-64, pepstatin A,
and leupeptin as well as by the lysosomal vacuolar Hþ-ATPase
inhibitor baﬁlomycin A1 [12]. Thus, when A20 is silenced, TRIF and
TRAF6 may be selectively delivered into autophagosomes and
degraded by lysosomal enzymes via autophagy.
Formation of the phagophore is thought to occur from the
membranes of rER or possibly from the Golgi complex, mitochon-
drion, and plasma membranes [17]. These membranes have an
enzymatic complex of class III PI3K and vacuolar protein sorting-
associated protein 34 that includes the essential regulatory protein
Beclin-1 [18]. Initiation of phagophore formation depends on the
enzymatic activity of this complex to generate phosphatidylinositol
3-phosphates. Phagophore elongation is mediated by 2 regulatory
systems of autophagy proteins (ATGs). One involves the conjugation
of ubiquitin-like ATG12 to ATG5 to form a large E3 ubiquitin ligase-
like complex via further conjugation of ATG16L1. The other regula-
tory system involves the conjugation of phosphatidylethanolamine
(PE) to LC3 (an ATG8 ortholog in mammals) [19]. The conversion of
normal LC3 (LC3-I) to the PE-conjugated form (LC3-II) is considered
a hallmark response of autophagy ﬂux [20]. ATG7 regulates both
formation of the ATG5-ATG12-ATG16L1 complex and conjugation of
PE to LC3 [19]. We investigated the involvement of these autophagic
processes in TRIF and TRAF6 degradation. As described above, TRIF
and TRAF6 degradation was suppressed by 3-MA, an inhibitor of the
class III PI3K. However, silencing of the Beclin-1 gene did not affect
degradation of these molecules in A20-silenced cells [12]. In addi-
tion, silencing of the genes encoding ATG5 and ATG7 did not affect
degradation of TRIF and TRAF. Furthermore, LC3 conversion was not
induced after poly (I:C) treatment in A20-silenced cells. Thus, Beclin-
1, ATG5, ATG7, and LC3, all of which are involved in the ‘‘canonical’’
autophagic processes, may not be associated with TRIF and TRAF6
degradation. We were unable to determine why the autophagic
degradation of TRIF and TRAF6 does not depend on canonical
autophagic processes. However, the existence of ‘‘non-canonical’’
autophagic processes, which do not require these autophagic
proteins but are mediate d by the anti-apoptotic B cell lymphoma
extra large protein, has been reported [21].4. NDP52 mediates selective degradation of TRIF and TRAF6
Next, we investigated how TRIF and TRAF6 are selectively
degraded by autophagy. Autophagy has long been considered tobe nonspeciﬁc in the removal of cytosolic components. However,
recent studies have revealed that cytosolic constituents can be
selectively delivered into autophagosomes during a particular
type of stress-induced autophagy [22]. During selective autop-
hagy, posttranscriptional modiﬁcations of the target constituents,
of which polyUb is thought to be the primary modiﬁcation,
is required [22]. Targets with polyUb are recognized by autop-
hagy-associated ubiquitin-binding proteins (so-called autophagy
receptors), which enable sequestration of the target to form
cytoplasmic aggregates and autophagic clearance. So far, many
autophagy receptors, including sequestosome 1, neighbor of
breast cancer type 1 susceptibility protein 1, NIX/adenovirus
E1B 19 kDa protein-interacting protein 3-like, histone deacetylase
6, B cell lymphoma 2-associated athanogene 3, optineurin, and
NDP52, have been identiﬁed [22]. We tested whether autophagy
receptors mediate the selective degradation of TRIF by screening
the known autophagy receptors for the ability to interact with
TRIF, and only NDP52 was observed to interact with TRIF [12].
Furthermore, NDP52 gene knockdown signiﬁcantly restored poly
(I:C)-induced degradation of TRIF and TRAF6 in A20-silenced cells
(Fig. 2). Thus, NDP52 was identiﬁed to be a critical mediator of the
selective degradation of TRIF and TRAF6.
NDP52 (also known as CALCOCO2) was a recently identiﬁed
autophagy receptor that eliminates intracellular bacteria [23], but
its detailed function is largely unknown. NDP52 is ubiquitously
expressed in various tissues and cells and is mainly a cytosolic
protein [24]. Two vertebrate paralogs of NDP52, COCOA (also
known as CALCOCO1) and TAX1BP1 (also known as CALCOCO3),
are known. Human NDP52 contains a skeletal muscle and kidney-
enriched inositol phosphatase carboxyl homology (SKICH) domain
at the N terminal, an intermediate coiled-coil (CC) domain with a
leucine zipper sequence, and a Lin11, Isl-1, and Mec-3 (LIM)-like
domain containing 2 zinc ﬁngers at the C terminal. All these
domains are conserved in NDP52 proteins found in chimpanzees,
bovines, dogs, and chickens. However, mouse Ndp52 has a highly
mutated CC domain and completely lacks the LIM-like domain.
Therefore, the functions of NDP52 may be considerably different in
humans and mice because the LIM-like domain of NDP52 domain
has been suggested to speciﬁcally bind to polyubiquitin chains
conjugated to the intracellular bacterial surface [23]. We investi-
gated which domain is required for TRIF and TRAF6 interaction and
degradation. NDP52 mapping revealed that the SKICH domain was
required for binding to TRIF and TRAF6, whereas the LIM-like
domain was required for TRIF and TRAF6 degradation [12]. Thus,
NDP52 interacts with TRIF and TRAF6 through the SKICH domain
and possibly recognizes polyUb through the LIM-like domain.
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polyubiquitin, and this process is required for selective autopha-
gic removal of the targets [7,22]. We found that NDP52 markedly
increased aggregated TRAF6 in the cytoplasm [12]. In addition,
TRAF6 aggregates colocalized with NDP52 and proteins with
polyUb. Furthermore, under the condition of A20 silencing, TRAF6
aggregation clearly increased. Thus, NDP52 plays a role in the
aggregation of TRAF6 with polyubiquitin, and this process is
normally restricted by A20. Next, we examined how NDP52
aggregates TRAF6. Aggregation of intracellular proteins is usually
associated with accumulation of proteins with polyUb [24]. We
found that TRAF6 catalyzes polyUb of NDP52 [12]. When A20 is
silenced, NDP52 polyUb further increased. Thus, TRAF6-induced
polyUb of NDP52 may promote TRAF6 aggregation.5. NDP52 has the potential to negatively regulate
TLR signaling
NDP52 has the capability to induce selective autophagic
degradation of TRIF and TRAF6, though this induction is normally
inhibited by A20. Degradation of signaling molecules is generally
linked to downregulation of signal transduction. Therefore, we
investigated whether NDP52 negatively regulates TLR-mediated
signaling when A20 is silenced. Interestingly, silencing of NDP52
did not signiﬁcantly affect poly (I:C)-induced IL-6, IL-8, and
CXCL10 but silencing both A20 and NDP52 markedly induced
these molecules [12]. Thus, NDP52 effectively exerts a negative
regulatory affect on TLR signaling only when expression of A20 is
silenced.6. Conclusions
The deubiquitinase A20 serves as a potent suppressor of TLR-
mediated signal transduction through the removal of polyubiqui-
tin from TRAF6, TRAF3, and RIP1. Our study indicates that A20
suppresses induction of autophagy by inhibiting the autophagy
receptor NDP52, which mediates selective autophagic clearance
of TRIF and TRAF6 after it undergoes polyUb by TRAF6. Therefore,
only in the absence of A20, NDP52 can be fully activated by
TRAF6. Activated NDP52 mediates aggregation of TRIF and TRAF6.
This process may be important for their selective autophagic
degradation in lysosomes. In the absence of A20, NDP52-
mediated autophagy ultimately leads to negative regulation of
TLR signaling. Thus, the ﬁne-tuning effect of NDP52 on TLR
signaling is paradoxically downregulated by A20, which is known
as a signaling ﬁne-tuner to prevent excess TLR signaling.
Although the biological signiﬁcance of such an unanticipated
regulatory mechanism is currently unclear, future research
should address this question. In addition, it will be important to
elucidate how NDP52-associated autophagy affects TLR-induced
innate immune responses in healthy periodontal tissue or inﬂam-
matory processes in infected periodontal tissue.Conﬂict of interest
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